L. K. Harper
Effects of the A2A adenosine receptor antagonist KW6002 in the nucleus accumbens in vitro and in vivo
Harper, L. K.; Beckett, S. R.; Marsden, C. A.; McCreary, A. C.; Alexander, S. P.H.
Authors
S. R. Beckett
C. A. Marsden
A. C. McCreary
Dr Steve Alexander steve.alexander@nottingham.ac.uk
ASSOCIATE PROFESSOR
Abstract
In this study, we have used the selective A2A adenosine receptor antagonist KW6002 to investigate the function of A2A receptors in the Lister hooded rat nucleus accumbens in vitro and in vivo. Radioligand binding studies confirmed a greater than 50-fold selectivity of KW6002 for A2A receptors compared to A1 receptors. Release of [ 3H]-dopamine from nucleus accumbens slices in vitro was almost doubled in the presence of 300 nM KW6002, while GABA release was inhibited by approximately one third. In vivo, intraperitoneal administration of KW6002 (4 mg kg- 1) increased dopamine overflow almost 4-fold in the nucleus accumbens. In behavioural testing, KW6002 elicited place preference and increased locomotor activity at 1, 2 and 4 mg kg- 1. Taken together, these results suggest a role for tonic activation of A2A adenosine receptors in reward-related phenomena. © 2006 Elsevier Inc. All rights reserved.
Citation
Harper, L. K., Beckett, S. R., Marsden, C. A., McCreary, A. C., & Alexander, S. P. (2006). Effects of the A2A adenosine receptor antagonist KW6002 in the nucleus accumbens in vitro and in vivo. Pharmacology Biochemistry and Behavior, 83(1), 114-121. https://doi.org/10.1016/j.pbb.2005.12.014
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 20, 2005 |
Online Publication Date | Jan 31, 2006 |
Publication Date | Jan 1, 2006 |
Deposit Date | Dec 3, 2022 |
Journal | Pharmacology Biochemistry and Behavior |
Print ISSN | 0091-3057 |
Electronic ISSN | 1873-5177 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 83 |
Issue | 1 |
Pages | 114-121 |
DOI | https://doi.org/10.1016/j.pbb.2005.12.014 |
Public URL | https://nottingham-repository.worktribe.com/output/14322259 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S0091305705004041?via%3Dihub |
You might also like
Natural product pharmacology: the British Journal of Pharmacology perspective
(2024)
Journal Article
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
(2024)
Journal Article
The IUPHAR/BPS Guide to PHARMACOLOGY in 2024
(2023)
Journal Article
Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search